Back to BlackRock, Inc. BlackRock, Inc.

PTCTPTCT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PTC THERAPEUTICS INC

BlackRock, Inc. holds 14M shares of PTCT (PTC THERAPEUTICS INC), worth $1.1B as of 2026-Q2. The position was increased (+7.8% shares). PTCT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$1.1B

Current Shares

14M

Total Value Change

+$782.5M

Total Shares Change

+6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
14M
+7.8%
$1.1B0.0%$81.57
34
2026-Q1
Increased
12.9M
+1.3%
$882.2M0.0%$64.39
32
2025-Q4
Increased
12.8M
+79.2%
$970.7M0.0%$76.19
49
2025-Q3
Decreased
7.1M
-4.7%
$437.6M0.0%$60.65
0
2025-Q2
Decreased
7.5M
-3.7%
$365.3M0.0%$49.84
0
2025-Q1
Decreased
7.8M
-1.6%
$395.9M0.0%$54.24
0
2024-Q4
New
7.9M
-
$356.6M0.0%$45.77
43

Other major holders of PTCT: VANGUARD GROUP INC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used